Sarepta Therapeutics Stock Price History
SRPT Stock | USD 37.60 1.01 2.62% |
Below is the normalized historical share price chart for Sarepta Therapeutics extending back to June 04, 1997. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sarepta Therapeutics stands at 37.60, as last reported on the 1st of June, with the highest price reaching 38.15 and the lowest price hitting 36.96 during the day.
If you're considering investing in Sarepta Stock, it is important to understand the factors that can impact its price. Sarepta Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.19, which indicates the firm had a -0.19 % return per unit of risk over the last 3 months. Sarepta Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sarepta Therapeutics' Risk Adjusted Performance of (0.34), coefficient of variation of (498.13), and Variance of 43.73 to confirm the risk estimate we provide. At this time, Sarepta Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 113.3 M in 2025, whereas Capital Stock is likely to drop 9,429 in 2025. . Price Earnings Ratio is likely to gain to 51.60 in 2025, whereas Price To Sales Ratio is likely to drop 5.77 in 2025. Sarepta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of June 1997 | 200 Day MA 103.4985 | 50 Day MA 52.8594 | Beta 0.84 |
Sharpe Ratio = -0.1933
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SRPT |
Estimated Market Risk
6.67 actual daily | 59 59% of assets are less volatile |
Expected Return
-1.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sarepta Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sarepta Therapeutics by adding Sarepta Therapeutics to a well-diversified portfolio.
Price Book 3.2337 | Enterprise Value Ebitda 99.0605 | Price Sales 1.6545 | Shares Float 93.9 M | Wall Street Target Price 89.9588 |
Sarepta Therapeutics Stock Price History Chart
There are several ways to analyze Sarepta Stock price data. The simplest method is using a basic Sarepta candlestick price chart, which shows Sarepta Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 6, 2025 | 105.56 |
Lowest Price | May 15, 2025 | 35.27 |
Sarepta Therapeutics June 1, 2025 Stock Price Synopsis
Various analyses of Sarepta Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sarepta Stock. It can be used to describe the percentage change in the price of Sarepta Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sarepta Stock.Sarepta Therapeutics Price Daily Balance Of Power | (0.85) | |
Sarepta Therapeutics Price Rate Of Daily Change | 0.97 | |
Sarepta Therapeutics Price Action Indicator | (0.46) |
Sarepta Therapeutics June 1, 2025 Stock Price Analysis
Sarepta Stock Price History Data
The price series of Sarepta Therapeutics for the period between Mon, Mar 3, 2025 and Sun, Jun 1, 2025 has a statistical range of 72.4 with a coefficient of variation of 36.5. The price distribution for the period has arithmetic mean of 64.1. The median price for the last 90 days is 60.85. The company completed stock split (1:6) on 12th of July 2012.Open | High | Low | Close | Volume | ||
06/01/2025 | 38.05 | 38.15 | 36.96 | 37.60 | ||
05/30/2025 | 38.05 | 38.15 | 36.96 | 37.60 | 3,085,589 | |
05/29/2025 | 37.54 | 38.79 | 36.98 | 38.61 | 2,484,089 | |
05/28/2025 | 38.33 | 39.35 | 36.89 | 37.23 | 3,272,059 | |
05/27/2025 | 38.34 | 39.56 | 37.88 | 38.35 | 4,242,577 | |
05/23/2025 | 38.00 | 38.41 | 37.64 | 37.90 | 2,053,921 | |
05/22/2025 | 39.67 | 40.10 | 38.69 | 38.79 | 3,742,373 | |
05/21/2025 | 41.01 | 44.14 | 39.96 | 40.05 | 8,429,781 | |
05/20/2025 | 38.02 | 40.70 | 37.15 | 39.99 | 4,911,738 | |
05/19/2025 | 35.99 | 38.36 | 35.85 | 37.94 | 3,664,098 | |
05/16/2025 | 35.64 | 36.72 | 35.25 | 36.43 | 4,046,027 | |
05/15/2025 | 35.70 | 35.70 | 34.10 | 35.27 | 3,896,257 | |
05/14/2025 | 36.25 | 37.42 | 35.56 | 35.74 | 5,217,022 | |
05/13/2025 | 36.57 | 37.32 | 34.90 | 36.20 | 5,664,175 | |
05/12/2025 | 37.70 | 39.21 | 36.21 | 36.37 | 8,369,292 | |
05/09/2025 | 37.32 | 39.66 | 35.93 | 36.27 | 6,619,551 | |
05/08/2025 | 37.26 | 38.03 | 35.46 | 36.52 | 9,241,065 | |
05/07/2025 | 39.99 | 40.00 | 36.59 | 36.72 | 20,730,762 | |
05/06/2025 | 62.93 | 63.92 | 46.52 | 46.75 | 15,763,440 | |
05/05/2025 | 63.41 | 64.80 | 63.12 | 63.66 | 2,091,863 | |
05/02/2025 | 63.50 | 64.30 | 63.02 | 63.51 | 1,395,887 | |
05/01/2025 | 62.45 | 64.00 | 60.53 | 62.78 | 1,360,542 | |
04/30/2025 | 59.98 | 62.51 | 59.62 | 62.40 | 1,577,027 | |
04/29/2025 | 61.37 | 62.13 | 60.55 | 60.85 | 1,993,605 | |
04/28/2025 | 60.59 | 62.47 | 60.18 | 61.51 | 1,155,727 | |
04/25/2025 | 61.68 | 61.92 | 59.96 | 60.44 | 1,312,947 | |
04/24/2025 | 59.63 | 61.91 | 58.76 | 61.76 | 1,561,733 | |
04/23/2025 | 61.65 | 62.78 | 59.06 | 59.49 | 1,929,978 | |
04/22/2025 | 55.66 | 59.33 | 55.52 | 59.31 | 2,508,479 | |
04/21/2025 | 53.40 | 56.11 | 52.80 | 55.23 | 1,467,400 | |
04/17/2025 | 53.70 | 55.49 | 53.56 | 53.79 | 1,912,279 | |
04/16/2025 | 54.59 | 55.01 | 53.02 | 53.94 | 1,440,158 | |
04/15/2025 | 54.09 | 56.34 | 53.23 | 54.42 | 2,215,231 | |
04/14/2025 | 53.34 | 54.64 | 51.39 | 54.63 | 2,310,611 | |
04/11/2025 | 51.22 | 51.80 | 49.09 | 51.03 | 4,036,734 | |
04/10/2025 | 53.34 | 54.47 | 49.86 | 50.31 | 2,904,771 | |
04/09/2025 | 48.55 | 57.70 | 48.01 | 55.65 | 4,270,381 | |
04/08/2025 | 53.99 | 55.36 | 48.94 | 49.30 | 3,549,223 | |
04/07/2025 | 51.59 | 55.17 | 50.61 | 52.40 | 4,155,458 | |
04/04/2025 | 59.22 | 59.45 | 54.26 | 54.43 | 4,576,844 | |
04/03/2025 | 57.22 | 60.24 | 57.14 | 58.61 | 3,759,361 | |
04/02/2025 | 61.69 | 64.22 | 60.70 | 62.47 | 3,804,942 | |
04/01/2025 | 64.37 | 65.69 | 61.53 | 61.91 | 3,548,811 | |
03/31/2025 | 65.90 | 67.47 | 62.50 | 63.82 | 4,633,804 | |
03/28/2025 | 71.88 | 72.05 | 69.81 | 70.41 | 984,524 | |
03/27/2025 | 72.98 | 73.95 | 71.25 | 71.81 | 1,364,994 | |
03/26/2025 | 73.88 | 74.40 | 70.91 | 72.88 | 1,387,340 | |
03/25/2025 | 76.13 | 76.26 | 72.17 | 73.61 | 1,303,549 | |
03/24/2025 | 74.67 | 76.67 | 74.44 | 76.33 | 1,874,685 | |
03/21/2025 | 73.32 | 75.50 | 73.05 | 74.10 | 2,592,686 | |
03/20/2025 | 80.18 | 80.26 | 73.06 | 73.45 | 3,590,702 | |
03/19/2025 | 75.18 | 80.98 | 75.13 | 79.97 | 5,039,529 | |
03/18/2025 | 78.61 | 81.87 | 73.06 | 73.54 | 13,399,748 | |
03/17/2025 | 97.35 | 103.32 | 97.35 | 101.35 | 925,423 | |
03/14/2025 | 99.00 | 100.00 | 97.06 | 97.19 | 874,134 | |
03/13/2025 | 99.65 | 100.01 | 97.11 | 98.37 | 736,577 | |
03/12/2025 | 101.72 | 102.40 | 99.02 | 99.77 | 756,307 | |
03/11/2025 | 99.16 | 101.56 | 97.91 | 100.71 | 1,019,724 | |
03/10/2025 | 101.84 | 102.15 | 98.82 | 99.69 | 1,639,189 | |
03/07/2025 | 104.02 | 104.85 | 102.00 | 103.03 | 1,160,008 | |
03/06/2025 | 106.79 | 107.23 | 104.39 | 105.56 | 888,973 |
About Sarepta Therapeutics Stock history
Sarepta Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sarepta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sarepta Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sarepta Therapeutics stock prices may prove useful in developing a viable investing in Sarepta Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 107.9 M | 113.3 M | |
Net Loss | -633.1 M | -601.5 M |
Sarepta Therapeutics Quarterly Net Working Capital |
|
Sarepta Therapeutics Stock Technical Analysis
Sarepta Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Sarepta Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sarepta Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Sarepta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sarepta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.34) | |||
Jensen Alpha | (1.28) | |||
Total Risk Alpha | (1.19) | |||
Treynor Ratio | (0.86) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Sarepta Stock Analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.